LCS 1 - ≥98% , CAS No.41931-13-9

CAS: 41931-13-9 Cat. No.: L341838 Summenformel: C11H8Cl2N2O Molekulargewicht: 255.1
Zu bestellen verfügbar
QUALITÄT & REINHEIT ≥98%
Synonyms
4,5-dichloro-2-m-tolylpyridazin-3(2H)-one|4,5-Dichloro-2-(m-tolyl)pyridazin-3(2H)-one|4,5-Dichloro-2-(3-methylphenyl) pyridazin-3(2H)-one|4,5-dichloro-2-(3-methylphenyl)-3(2H)-pyridazinone|1,4,5-dichloro-2-m-tolylpyridazin-3(2H)-one|Cambridge id 5352460|4,5-dichloro-2-(3-methylphenyl)pyridazin-3-one|4,5-dichloro-2-(3-methylphenyl)pyridazin-3(2H)-one|LCS-1|LCS 1|Lung Cancer Screen 1
Storage
Store at 2-8°C,Protected from light
Shipped In
Wet ice
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
L341838-5mg
—
2 Auf Lager
8,59€
25mg
L341838-25mg
—
2 Auf Lager
9,46€
250mg
L341838-250mg
—
3 Auf Lager

18,14€

27,68€
Speichern 9,55 € (34.48%)
1g
L341838-1g
—
3 Auf Lager

42,43€

64,13€
Speichern 21,69 € (33.83%)
5g
L341838-5g
—
3 Auf Lager

123,13€

184,74€
Speichern 61,61 € (33.35%)
Enter a quantity for the sizes you want to add.

Übersicht

LCS 1 is an inhibitor of SOD1 (superoxide dismutase 1), an enzyme that catalyzes the conversion of superoxide ion (O|2|-) into H|2|O|2|and O|2|to maintain low levels of reactive oxygen species. LCS 1 has been shown to inhibit the proliferation of lung adenocarcinoma cell lines.

Spezifikationen

Synonyme
4,5-dichloro-2-m-tolylpyridazin-3(2H)-one | 4,5-Dichloro-2-(m-tolyl)pyridazin-3(2H)-one | 4,5-Dichloro-2-(3-methylphenyl) pyridazin-3(2H)-one | 4,5-dichloro-2-(3-methylphenyl)-3(2H)-pyridazinone | 1,4,5-dichloro-2-m-tolylpyridazin-3(2H)-one | Cambridge id 5352460 | 4,5-dichloro-2-(3-methylphenyl)pyridazin-3-one | 4,5-dichloro-2-(3-methylp Show more
Spezifikationen & Reinheit
≥98%
Biochemische und physiologische Mechanismen
LCS-1 is an inhibitor of superoxide dismutase (SOD1). LCS-1 inhibits the proliferation of lung adendocarcinoma cell lines.
Storage
Store at 2-8°C,Protected from light
Verschickt in
Wet ice
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Aktionsart
INHIBITOR
Reinheit
≥98%
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504760144
SMILES
CC1=CC(=CC=C1)N2C(=O)C(=C(C=N2)Cl)Cl
IUPAC Name
4,5-dichloro-2-(3-methylphenyl)pyridazin-3-one
InChIKey
SYUPLLHVMCLXEM-UHFFFAOYSA-N
InChI
1S/C11H8Cl2N2O/c1-7-3-2-4-8(5-7)15-11(16)10(13)9(12)6-14-15/h2-6H,1H3
Isomere SMILES
CC1=CC(=CC=C1)N2C(=O)C(=C(C=N2)Cl)Cl
UN-Nummer
2811
Verpackungsgruppe
III
Molekulargewicht
255.1
Reaxy-Rn
790931
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=790931&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlasseDiazines
SubclassPyridazines and derivatives
Intermediate Tree Nodes Not available
Direct ParentPyridazinones
Alternative Parents Toluenes  Aryl chlorides  Vinylogous halides  Heteroaromatic compounds  Lactams  Azacyclic compounds  Organopnictogen compounds  Organooxygen compounds  Organonitrogen compounds  Organochlorides  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Pyridazinone - Toluene - Aryl chloride - Aryl halide - Monocyclic benzene moiety - Benzenoid - Heteroaromatic compound - Vinylogous halide - Lactam - Azacycle - Organic nitrogen compound - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Organochloride - Organohalogen compound - Organic oxide - Organopnictogen compound - Organic oxygen compound - Aromatic heteromonocyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as pyridazinones. These are compounds containing a pyridazine ring which bears a ketone.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
PTH1R Tclin Parathyroid hormone receptor (47172 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLP1R Tclin Glucagon-like peptide 1 receptor (111429 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BJ (6930 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GNAS Tbio Guanine nucleotide-binding protein G(s), subunit alpha (103405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SMAD3 Tchem Mothers against decapentaplegic homolog 3 (68039 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPC1 Tchem Niemann-Pick C1 protein (18985 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GMNN Tbio Geminin (128009 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAB9A Tbio Ras-related protein Rab-9A (22488 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MBNL1 Tbio Muscleblind-like protein 1 (34431 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
microRNA 21 (64692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATAD5 Tbio ATPase family AAA domain-containing protein 5 (122566 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APOBEC3G Tchem DNA dC->dU-editing enzyme APOBEC-3G (12481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IDH1 Tclin Isocitrate dehydrogenase [NADP] cytoplasmic (40980 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CGA Tbio Glycoprotein hormones alpha chain (29278 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PAX8 Tchem Paired box protein Pax-8 (1910 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TGR Thioredoxin glutathione reductase (28579 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bla(tem-2) Beta Lactamase (819 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LMP1 Latent membrane protein 1 (726 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

7 results found

Lot NumberCertificate TypeDatumArtikel
K2527045K2527045Certificate of AnalysisDec 10, 2025 L341838
C2224483C2224483Certificate of AnalysisJan 13, 2025 L341838
C2224484C2224484Certificate of AnalysisJan 13, 2025 L341838
C2224485C2224485Certificate of AnalysisJan 13, 2025 L341838
C2224486C2224486Certificate of AnalysisJan 13, 2025 L341838
C2224487C2224487Certificate of AnalysisJan 13, 2025 L341838
F2425020F2425020Certificate of AnalysisJan 22, 2022 L341838
Chemische und physikalische Eigenschaften
LöslichkeitSoluble in DMSO (50 mg/ml). Insoluble in water.
EmpfindlichkeitLight sensitive
Brechungsindexn20D1.63 (Predicted)
Siedepunkt (°C)~339.6° C at 760 mmHg (Predicted)
Schmelzpunkt (°C)117° C
Molekulargewicht255.100 g/mol
XLogP32.400
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass254.001 Da
Monoisotopic Mass254.001 Da
Topological Polar Surface Area32.700 Ų
Heavy Atom Count16
Formal Charge0
Complexity365.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Citations of This Product
Lösungsrechner
Bewertungen

Kundenbewertungen

Application Protocols

No tested applications or recommended protocols are provided in the Product Data for this item.

General small‑molecule handling protocol (research use only)

  • Upon receipt, inspect packaging integrity and confirm cold shipment (wet ice) was maintained.
  • Allow the container to equilibrate to 2–8 °C before opening to minimize condensation; keep protected from light.
  • If a solution: note solvent, concentration, and any stabilizers; aliquot under low light into amber vials to reduce freeze–thaw and light exposure.
  • If a solid: rapidly weigh under low light, then prepare a concentrated stock in a compatible solvent (commonly DMSO for screening) after a brief solubility check.
  • Filter stocks through 0.22 µm PTFE/nylon (as compatible) if particulate is observed; record final concentration by gravimetry or quantitative NMR if needed.
  • Store aliquots at 2–8 °C protected from light unless the CoA specifies otherwise.

For any specialized application (e.g., biochemical assay, materials use), develop and validate protocols internally with appropriate controls.

Biological Roles

No biological or mechanistic information is provided in the Product Data for this item, and no claims are made here regarding cellular targets, pathways, or phenotypes.

  • Research Use Only: As stated in the Product Data, this product is for research use only and is not intended for diagnostic or therapeutic procedures.
  • If the material is intended as a tool compound, users should determine biological activity empirically under their assay conditions, confirming identity, purity, and solution stability beforehand.
  • Establish vehicle controls (e.g., matched DMSO %) and perform concentration–response testing over a suitable range with replicate measurements.
  • Evaluate stability in relevant biological media (e.g., buffer, serum, cell culture media) by LC–MS to rule out degradation or adsorption artifacts during the assay window.

Any statements about biological roles, targets, or mechanisms should be based on primary data generated in your laboratory or on peer‑reviewed literature specifically matched to the exact CAS/lot of interest.

Buffer Applications

This product is not described as a buffering agent, and no acid/base characteristics (pKa, protonation state) are provided in the Product Data. Therefore, no standard buffer formulations can be recommended for this item.

  • If the compound must be prepared in aqueous buffer for biological assays, select the buffer system based on your assay’s requirements (e.g., PBS pH 7.4, HEPES pH 7.2–7.6, Tris pH 7.5–8.5) and first confirm the compound’s stability and solubility over the desired pH range.
  • Avoid prolonged exposure to light during aqueous preparation, consistent with the storage instruction “protect from light.”

For dedicated buffer components and recipes, please refer to buffer‑grade reagents with specified pKa and buffering ranges.

Green Alternatives

Without structural or solvent‑use context, specific greener substitutes for LCS 1 cannot be identified. The following general strategies help reduce environmental impact when working with small‑molecule research reagents.

  • Prefer safer solvents consistent with ACS GCI/Pharma solvent selection guides:
    • Favor water, ethanol, isopropanol, ethyl acetate, 2‑MeTHF, CPME where technically feasible.
    • Reduce use of chlorinated and high‑toxicity solvents (e.g., dichloromethane, DMF, NMP) unless necessary for performance.
  • Minimize DMSO concentration in biological assays to ≤0.5–1% v/v to reduce cytotoxicity and waste burden.
  • Scale reactions and assays judiciously to limit chemical consumption and waste; employ microscale workflows for screening.
  • Use energy‑efficient conditions (ambient temperature/pressure) when compatible with compound stability.

Illustrative solvent comparison (general guidance)

| Use case | Conventional choice | Greener alternative | Trade‑offs | |---|---|---|---| | Nonpolar extraction | Hexane | Cyclopentyl methyl ether (CPME) | Different selectivity; peroxide management still required. | | Ether solvent | THF | 2‑MeTHF | Improved sustainability; different miscibility and water content handling. | | Polar aprotic | DMF/NMP | Cyrene, propylene carbonate | Viscosity and solubility profiles differ; method re‑optimization needed. |

Select alternatives only after confirming compound solubility and stability.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or formulation specifications are provided for this item. Accordingly, no pharmaceutical use is claimed or implied.

  • If used in pre‑formulation research as a tool or reference material, document solvent/vehicle composition, concentration, and stability data. Ensure that any use remains within non‑clinical, research‑only settings.
  • For analytical method development (e.g., LC method benchmarking), confirm purity and assign retention factors under your chromatographic conditions.

Note: This product is supplied for research use only and is not for use in humans or in manufacturing of pharmaceuticals intended for human or veterinary administration.

Physical Properties

Item-specific physical constants are not included in the Product Data for this catalog entry. The following table summarizes what is and is not specified.

| Property | Status | |---|---| | Appearance | Not specified for this item; refer to CoA/Spec Sheet. | | Melting point | Not specified for this item; refer to CoA/Spec Sheet. | | Boiling point | Not specified for this item; refer to CoA/Spec Sheet. | | Density | Not specified for this item; refer to CoA/Spec Sheet. | | Refractive index | Not specified for this item; refer to CoA/Spec Sheet. | | Solubility | Not specified for this item; refer to CoA/Spec Sheet. | | LogP/logD | Not specified for this item; refer to CoA/Spec Sheet. | | pKa | Not specified for this item; refer to CoA/Spec Sheet. | | UV–Vis characteristics | Not specified for this item; refer to CoA/Spec Sheet. |

Practical guidance when properties are unspecified (general)

  • Perform a small‑scale solubility screen in typical laboratory solvents (e.g., water, PBS, MeOH, EtOH, acetonitrile, DMSO, DMF) before committing to an assay or formulation.
  • If light sensitivity is suspected (storage guidance states “protect from light”), minimize exposure by using amber glassware and subdued lighting when preparing solutions.
  • Record observed phase behavior and any color changes; correlate with LC–MS/HPLC to assess stability during handling.
Quality and Grades
  • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Interpreting grades (general guidance)

  • If supplied as research grade, typical expectations include identity confirmation (e.g., NMR/LC–MS) and purity reported by HPLC/GC area %. Absence of detailed impurity profiles may limit use in regulated studies.
  • Analytical/Reference standard grades (if applicable) provide enhanced characterization: certified purity, homogeneity, and traceability. Request supporting documentation if needed for calibration or method validation.
  • For chromatography‑grade solvents/reagents, low UV cutoff and low residue specs are relevant; no such claims are present in the Product Data for this item.

Stabilizers and additives

  • No stabilizer information is supplied in the Product Data. If long‑term stability is a concern (light‑sensitive storage is indicated), ask for inhibitor content, residual solvent, or salt/form details on the CoA.

Recommended QC on receipt (best practice)

  • Verify identity by LC–MS (accurate mass/fragmentation) and 1H NMR.
  • Check purity by HPLC with diode‑array detection (if chromophoric) or ELSD; document storage lot conditions.
  • If the compound is used as a tool reagent, record solution prep, pH (if aqueous), and light exposure history to ensure reproducibility.
Reaction and Applications

The Product Data do not define functional groups or reactivity, so synthetic reaction guidance specific to LCS 1 cannot be provided. However, items labeled with screening codes (e.g., “LCS”) are often employed as small‑molecule tool compounds or as reference materials in discovery workflows.

Potential research applications (general, non‑clinical)

  • Biochemical assay tool: Evaluate activity in enzyme or binding assays once solubility and stability are established. Use serial dilutions from a DMSO stock, maintaining constant vehicle across conditions.
  • Method development control: Serve as a system suitability or retention‑time marker in analytical LC when method robustness is being established (after identity and purity are verified for this lot).
  • Probe development starting point: If structural information becomes available, analog synthesis and SAR exploration can proceed with parallel chemistry and orthogonal readouts.

Practical considerations

  • Confirm chemical stability in your chosen solvent and at assay temperature by time‑course HPLC/LC–MS.
  • Implement light protection consistent with the stated storage requirement (amber vials, foil‑wrapped autosampler vials).
  • If coupling to biological matrices (e.g., microsomes, plasma), pre‑screen for non‑specific binding and adsorption to plastics/glass.

For any reaction chemistry use, obtain the full structural data and impurity profile to ensure compatibility with planned transformations.

Reaction Conditions

No reaction condition guidance can be provided without knowledge of the compound’s functional groups or reactivity. If you intend to use this material in chemical transformations, first establish the following under small‑scale screening conditions:

  • Solvent compatibility: Screen polar aprotic (DMSO, DMF, MeCN), protic (MeOH, EtOH), and nonpolar (toluene, EtOAc) as relevant; verify stability by LC–MS over time.
  • pH/acid–base tolerance: Short exposures to mild base (e.g., DIPEA, K2CO3) and acid (AcOH, TFA 0.1–1%) can reveal liabilities; quench and analyze promptly.
  • Temperature limits: Ramp from 0 °C to 60 °C in your chosen medium to observe decomposition on HPLC.
  • Photostability: Given the “protect from light” storage note, perform side‑by‑side light/dark controls during reactions or assays.

Report any validated conditions in your ELN with full analytical traces to ensure reproducibility and to inform future users.

Safety and Handling

Safety details in the Product Data are incomplete. Always consult the SDS for authoritative hazard classification and first‑aid instructions.

  • GHS signal word: Not specified for this item; refer to SDS.
  • GHS pictograms: Not specified for this item; refer to SDS.
  • H‑statements: Not specified for this item; refer to SDS.
  • Storage conditions (Product Data): Store at 2–8 °C, protected from light.
  • Shipping (Product Data): Shipped on wet ice (suggests temperature‑sensitive but not frozen).

General laboratory precautions (applicable best practices)

  • Wear appropriate PPE: lab coat, safety glasses, and chemically resistant gloves.
  • Handle in a well‑ventilated area or fume hood to avoid inhalation of vapors/particulates of unknown toxicity.
  • Avoid light exposure during handling and storage; use amber vials or foil wrap.
  • Prevent contact with strong oxidizers/reductants, strong acids/bases until compatibility is known.
  • Dispose of waste according to institutional and local regulations; segregate halogenated vs non‑halogenated solvent waste if solvents are used.

First‑aid overview (defer to SDS for details)

  • In case of skin/eye contact: rinse with water for at least 15 minutes and remove contaminated clothing; seek medical attention.
  • If inhaled: move to fresh air; seek medical attention if symptoms occur.
  • If ingested: rinse mouth; do not induce vomiting; seek medical attention.

Note: Absence of hazard data is not evidence of safety. Treat as potentially hazardous until data are reviewed.

Solvent Selection

Item‑specific solubility data are not provided. The guidance below outlines a rational small‑molecule solubility/vehicle screening workflow.

  • Start with a tiered solvent screen (small scale, 1–5 mg):
    • Polar aprotic: DMSO, DMF, acetonitrile.
    • Protic: methanol, ethanol, isopropanol.
    • Aqueous: water, PBS (pH 7.4), acetate buffer (pH 5), Tris buffer (pH 8).
  • Use incremental additions and vortex/sonication; record concentrations at which clear solutions persist after 30 min at room temperature and after cooling.
  • If aqueous solubility is poor, consider co‑solvent systems (e.g., 10–50% DMSO or ethanol in buffer) or cyclodextrin inclusion (e.g., 10–20% w/v HP‑β‑CD) as appropriate for biological assays.
  • For light‑sensitive materials, conduct preparation in amber glassware and minimize exposure.

Comparison notes (general)

  • DMSO maximizes solubility for many heteroaromatics; highly miscible with water for titration into assays but can affect cells/enzymes above ~0.5–1% v/v.
  • Ethanol/MeOH are useful volatile vehicles for chemical reactions and some bioassays; consider evaporation impact and assay tolerance.
  • Aqueous buffers are preferred for biochemical assays if the compound is sufficiently ionizable; adjust pH only after confirming stability across the range.

Document your selected solvent and concentration on the batch record for reproducibility.

Storage and Reconstitution
  • Storage (Product Data): Store at 2–8 °C, protected from light.
  • Shipping (Product Data): Shipped on wet ice.
  • Form/appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Concentration/solvent (if solution): Not specified for this item; refer to CoA/Spec Sheet.

General reconstitution and handling guidance (when specifics are unknown)

  • If supplied as a solid/lyophilizate:
    • Allow vial to reach 2–8 °C before opening; handle under reduced light.
    • Prepare a primary stock in a suitable solvent (commonly DMSO for small‑molecule tools) after a brief solubility screen. Record exact concentration and solvent.
    • If aqueous use is required, dilute the organic stock into buffer with vigorous mixing while maintaining constant vehicle % across samples.
  • If supplied as a solution:
    • Verify the solvent system and concentration on the label/CoA.
    • Aliquot into amber vials to avoid repeated freeze–thaw and minimize headspace; store at 2–8 °C in the dark.

Stability tips

  • Minimize light exposure during weighing/prep (amber glassware, foil wrap).
  • Track preparation date, storage temperature, and any observed changes (color, precipitate); confirm integrity by HPLC/LC–MS prior to critical experiments.

For definitive instructions (reconstitution solvent, target concentration, shelf life), consult the lot‑specific CoA or Spec Sheet.

Structure and Identity

Concise identity summary based on the catalog listing. Structural identifiers are not fully available from the Product Data for this SKU.

  • Product name (catalog): LCS 1
  • SKU: L341838
  • CAS: 41931-13-9 (Product Data)
  • CID: 779573 (Product Data)
  • InChIKey: 348948 (Product Data; note: this format appears non‑standard for an InChIKey; verify on the CoA/SDS)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural description

  • Product Data do not include a 2D structure, functional group annotations, ring systems, or stereochemical information. Consequently, a text description of the scaffold cannot be provided without additional documentation. Please consult the CoA, Spec Sheet, or SDS for definitive structural identifiers.

Notes on identity control (general guidance)

  • For materials listed under screening codes (e.g., “LCS”), laboratories commonly verify identity by orthogonal techniques (e.g., 1H NMR, LC–MS with exact mass confirmation, and, where available, reference retention time).
  • If an analytical standard is required, request the most recent CoA specifying assay method, purity basis (w/w vs area %), and impurity profile.
Synthetic Utility

The Product Data do not include a structure or functional group information, so specific synthetic transformations cannot be recommended.

General considerations when adapting an unknown or undocumented small molecule for synthesis:

  • Obtain full structural identifiers (SMILES, InChI, NMR, HRMS) and review for reactive handles (e.g., halides, boronates, nitro, carbonyls, amines) to plan derivatization.
  • Assess chemical stability versus moisture, oxygen, and light; the storage note suggests potential light sensitivity.
  • If derivatization is desired (e.g., biotinylation, fluorescent tagging), first map labile motifs by stress testing (acid/base, redox, heat, photolysis) to avoid degrading the core.
  • For scale‑up or library synthesis, develop a compatibility matrix (solvent, base/acid, catalyst) guided by rapid parallel experimentation and in‑situ analytics (UPLC/ELSD).

In the absence of identity data, treat the material as a final tool compound rather than a building block until definitive characterization is available.

Target Specificity

No target, antigen, epitope, or binding specificity information is provided for this product. It is not listed as an antibody or biological macromolecule in the Product Data, and no application‑specific selectivity data are supplied.

  • If used as a tool compound in target engagement studies, determine specificity empirically (e.g., using enzymatic counterscreens, thermal shift assays/DSF, CETSA, SPR, or panel profiling) and document the exact lot, solvent, and assay conditions.
  • Avoid extrapolating target claims from unrelated materials with similar names; verify against the exact CAS: 41931‑13‑9 and supplier lot information.

Häufig gestellte Fragen

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at 2–8 °C, protected from light. The material is light-sensitive — keep it in its original opaque or amber container.
How is this product shipped?
This product ships chilled on wet ice. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 41931-13-9, the molecular formula is C11H8Cl2N2O, and the molecular weight is 255.1 g/mol. InChIKey SYUPLLHVMCLXEM-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.